Standard parenteral amino acid solutions available for neonates differ from standard adult parenteral amino acid solutions by having a higher content of

• A. cysteine
• B. phenylalanine
• C. taurine and tyrosine
• D. methionine and glycine

Answer: (C)

In newborns, certain amino acids become conditionally essential because their immature metabolism cannot keep up with rapid growth. Standard neonatal parenteral solutions are formulated with higher amounts of taurine and tyrosine to meet these needs.

Taurine is crucial for neonates even though it isn’t used to build proteins. It supports bile acid conjugation, retinal and CNS development, and osmoregulation. The infant liver can’t synthesize enough taurine, so it must be supplied in the PN solution.

Tyrosine becomes essential in neonates because the enzyme that converts phenylalanine to tyrosine (phenylalanine hydroxylase) is not fully mature yet. Providing extra tyrosine ensures adequate availability for protein synthesis and other vital functions.

Other choices don’t reflect this neonatal requirement as accurately.